Nasdaq:US$18.99 (+0.58) | HKEX:HK$30.35 (+1.05) | AIM:£3.04 (+0.08)
Search Result
Previous Article   |   Next Article
公告及新闻稿, 肿瘤学 / 免疫学 | 23 May 2007

Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China